Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies

被引:91
|
作者
Benoit, DD
Hoste, EA
Depuydt, PO
Offner, FC
Lameire, NH
Vandewoude, KH
Dhondt, AW
Noens, LA
Decruyenaere, JM
机构
[1] Ghent Univ Hosp, Med Intens Care Unit, Dept Internal Med, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Intens Care Med Div, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Div Hematol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium
关键词
acute renal failure; haematological malignancy; infection; intensive care unit; renal replacement therapy;
D O I
10.1093/ndt/gfh637
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Starting renal replacement therapy (RRT) for acute renal failure in critically ill patients with haematological malignancies is controversial because of the poor outcome and high costs. The aim of this study was to compare the outcome between critically ill medical patients with and without haematological malignancies who received RRT for acute renal failure. Methods. We retrospectively collected data on all consecutive patients who received RRT for acute renal failure at the Medical Intensive Care Unit (ICU) of a University Hospital between 1997 and 2002, and assessed the impact of the presence of a haematological malignancy on the survival within 6 months after ICU admission by Cox proportional hazard models. Results. Fifty of the 222 (22.5%) consecutive patients with haematological malignancies admitted to the ICU over the study period received RRT for acute renal failure compared with 248 of the 4293 (5.8%) patients without haematological malignancies (P < 0.001). Among patients who received RRT, those with haematological malignancies had higher crude ICU (79.6 vs 55.7%, P=0.002) and in-hospital (83.7 vs 66.1%, P = 0.016) mortality rates, and a higher mortality at 6 months (86 vs 72%, P = 0.018) by Kaplan-Meier estimates compared with those without haematological malignancies. However, after adjustment for the severity of illness and the duration of hospitalization before ICU admission, haematological malignancy by itself was no longer associated with a higher risk of death (hazard ratio 1.04; 95% confidence interval, 0.73-1.54, P = 0.78). Conclusions. Medical ICU patients with haematological malignancies have a higher rate of occurrence of acute renal failure treated with RRT and a higher mortality, compared with those without haematological malignancies. However, the presence of a haematological malignancy by itself is not a reason to withhold RRT in medical ICU patients with acute renal failure.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 50 条
  • [31] Renal replacement therapy: is it effective in critically ill patients with acute kidney injury?
    Schiffl, Helmut
    Lang, Susanne M.
    CRITICAL CARE, 2013, 17 (01):
  • [32] Renal replacement therapy: is it effective in critically ill patients with acute kidney injury?
    Helmut Schiffl
    Susanne M Lang
    Critical Care, 17
  • [33] Severe lactic acidosis in critically ill patients with acute kidney injury treated with renal replacement therapy
    De Corte, Wouter
    Vuylsteke, S.
    De Waele, Jan J.
    Dhondt, Annemieke W.
    Decruyenaere, Johan
    Vanholder, Raymond
    Hoste, Eric A. J.
    JOURNAL OF CRITICAL CARE, 2014, 29 (04) : 650 - 655
  • [34] Impact of anemia on outcome in critically ill patients with severe acute renal failure
    Damien du Cheyron
    Jean-Jacques Parienti
    Mohamed Fekih-Hassen
    Cédric Daubin
    Pierre Charbonneau
    Intensive Care Medicine, 2005, 31 : 1529 - 1536
  • [35] Influence of underlying disease on the outcome of critically ill patients with acute renal failure
    Schroeder, TH
    Hansen, M
    Dinkelaker, K
    Krueger, WA
    Nohé, B
    Fretschner, R
    Unertl, K
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 (11) : 848 - 853
  • [36] Impact of anemia on outcome in critically ill patients with severe acute renal failure
    du Cheyron, D
    Parienti, JJ
    Fekih-Hassen, M
    Daubin, C
    Charbonneau, P
    INTENSIVE CARE MEDICINE, 2005, 31 (11) : 1529 - 1536
  • [37] IMPROVING QUALITY OF ASSISTANCE AND OUTCOME IN CRITICALLY ILL PATIENTS WITH ACUTE RENAL FAILURE
    Sclauzero, P.
    Casarotto, S.
    Martingano, M.
    Morpurgo, F.
    Rocconi, I.
    Scala, K.
    Vescovi, M.
    Galli, G.
    JOURNAL OF RENAL CARE, 2006, 32 (03) : 167 - 170
  • [38] THE OUTCOME OF CRITICALLY ILL ELDERLY PATIENTS WITH SEVERE ACUTE-RENAL-FAILURE TREATED BY CONTINUOUS HEMODIAFILTRATION
    BELLOMO, R
    FARMER, M
    BOYCE, N
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1994, 17 (09): : 466 - 472
  • [39] Copeptin and acute renal failure in critically ill patients
    B Meyer
    A Bergmann
    P Wexberg
    J Struck
    NG Morgenthaler
    G Heinz
    R Pacher
    M Huelsmann
    Critical Care, 12 (Suppl 2):
  • [40] Diuretics in critically ill patients with acute renal failure
    Stefanec, T
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (11): : 1380 - 1380